Rossing P - Search Results

1

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.

Wheeler DC, Toto RD, Stefánsson BV, Jongs N, Chertow GM, Greene T, Hou FF, McMurray JJV, Pecoits-Filho R, Correa-Rotter R, Rossing P, Sjöström CD, Umanath K, Langkilde AM, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Wheeler DC, et al. Among authors: rossing p. Kidney Int. 2021 Jul;100(1):215-224. doi: 10.1016/j.kint.2021.03.033. Epub 2021 Apr 18. Kidney Int. 2021. PMID: 33878338 Free article. Clinical Trial.

2

Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.

Parving HH, Rossing P, Hommel E, Smidt UM. Parving HH, et al. Among authors: rossing p. Am J Kidney Dis. 1995 Jul;26(1):99-107. doi: 10.1016/0272-6386(95)90162-0. Am J Kidney Dis. 1995. PMID: 7611276 Clinical Trial.

3

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH. Hansen HP, et al. Among authors: rossing p. Kidney Int. 1995 Jun;47(6):1726-31. doi: 10.1038/ki.1995.238. Kidney Int. 1995. PMID: 7643542 Free article. Clinical Trial.

4

Monitoring kidney function in diabetic nephropathy.

Rossing P, Astrup AS, Smidt UM, Parving HH. Rossing P, et al. Diabetologia. 1994 Jul;37(7):708-12. doi: 10.1007/BF00417696. Diabetologia. 1994. PMID: 7958543

5

Reduction in albuminuria predicts diminished progression in diabetic nephropathy.

Rossing P, Hommel E, Smidt UM, Parving HH. Rossing P, et al. Kidney Int Suppl. 1994 Feb;45:S145-9. Kidney Int Suppl. 1994. PMID: 8158884 Clinical Trial.

6

Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.

Parving HH, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen F, Gall MA. Parving HH, et al. Among authors: rossing p. Am J Kidney Dis. 1993 Jul;22(1):188-95. doi: 10.1016/s0272-6386(12)70185-3. Am J Kidney Dis. 1993. PMID: 8322782

7

Calcium antagonists and the diabetic hypertensive patient.

Parving HH, Rossing P. Parving HH, et al. Among authors: rossing p. Am J Kidney Dis. 1993 Jun;21(6 Suppl 3):47-52. doi: 10.1016/0272-6386(93)70124-h. Am J Kidney Dis. 1993. PMID: 8503435 Review.

8

Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy.

Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P. Parving HH, et al. Among authors: rossing k, rossing p. Kidney Int. 1996 Jun;49(6):1778-82. doi: 10.1038/ki.1996.266. Kidney Int. 1996. PMID: 8743496 Free article.

9

Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy.

Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH. Hansen HP, et al. Among authors: rossing p. Kidney Int. 1996 Aug;50(2):579-85. doi: 10.1038/ki.1996.352. Kidney Int. 1996. PMID: 8840289 Free article.

10

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1997 Jul;46(7):1182-8. doi: 10.2337/diab.46.7.1182. Diabetes. 1997. PMID: 9200654 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

743 results

Search Page